Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Biocept Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 11 | 13 | +2 |
| Shares | 80.0K | 174.7K | +94.7K (+118.4%) |
| Value | $96.4K | $218.0K | +$121.6K (+126.2%) |
New holders (6)
Institutions that held Biocept Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 117,647 | $147.1K | 0.00% |
| Virtu Financial LLC | 13,777 | $17.0K | 0.00% |
| Two Sigma Securities, LLC | 12,718 | $15.9K | 0.00% |
| Geode Capital Management, LLC | 10,504 | $13.1K | 0.00% |
| Susquehanna International Group, LLP | 10,406 | $13.0K | 0.00% |
| UBS Group AG | 124 | $155 | 0.00% |
Sold out (4)
Institutions that held Biocept Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Anson Funds Management LP | 44,861 | $54.3K |
| Boothbay Fund Management, LLC | 23,529 | $28.5K |
| JPMorgan Chase & Co | 268 | $324 |
| Acadian Asset Management LLC | 247 | $0 |